Document is current
Any future updates will be listed below
-
Authors
Rossi, Ana B.
Mello, Adriana M.
Zahn, Joseph
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03346434 at ClinicalTrials.govDocuments that mention this clinical trial
Dupilumab Efficacy in Children with Atopic Dermatitis with Different Phenotypes and Endotypes: A Case Series
https://doi.org/10.1007/s12325-025-03150-6
Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
https://doi.org/10.1007/s12325-023-02753-1
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
https://doi.org/10.1007/s40272-023-00611-9
Long-Term Safety and Efficacy of Dupilumab Treatment in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
https://doi.org/10.1007/s40272-026-00747-4
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years
https://doi.org/10.1007/s13555-023-00960-w
-
Funding
Funding for this research was provided by:
Sanofi
Regeneron Pharmaceuticals
- License Information
-
More Information
Article History
Received: 30 December 2024
Accepted: 17 February 2025
First Online: 8 May 2025
Declarations
:
: Ana B. Rossi and Adriana M. Mello are employees of and may hold stock and/or stock options in Sanofi. Joseph Zahn is an employee and shareholder of Regeneron Pharmaceuticals Inc.
: The study was conducted in accordance with the Declaration of Helsinki, the International Conference on Harmonization Good Clinical Practice guidelines, and applicable regulatory requirements. An independent data and safety monitoring committee conducted blinded monitoring of patient safety data. The local Institutional Review Board or Ethics Committee at each study center oversaw trial conduct and documentation. The study was approved by the Copernicus Group ethics committee. All parents/guardians provided written informed consent before participating in the trial, including for the publication of clinical photos taken in selected centers. Pediatric patients provided assent according to the Ethics Committee (Institutional Review Board/Independent Ethics Committee)-approved standard practice for pediatric patients at each participating center.
